![Show Menu](styles/mobile-menu.png)
![Page Background](./../common/page-substrates/page0058.png)
58
PROGRAMME
| Programme and Exhibition Guide
RADIOBIOLOGY PRE-MEETING COURSE
Clinical application of biomarkers: how to discover, explore, and validate biomarkers
for normal tissue toxicity and tumour response
FRIDAY 5 MAY 2017
08:45-17:00 | LEHAR 4
Course directors: J. Alsner (DK) and MC. Vozenin (CH)
Course aim
Enable participants to understand the scientific and clinical aspects associated with
discovery, exploration, and validation of biomarkers for personalised/precision radiation
oncology (PRO) and raise awareness of key challenges in this important field.
Learning objectives
• To understand the basic principles of prognostic and predictive biomarkers
• To become familiar with biomarkers for normal tissue toxicity
• To become familiar with biomarkers for tumour response
• To appreciate the need for imaging and molecular biomarkers for PRO
• To understand the principles for validation of biomarkers
• To become familiar with legal and patent aspects for the clinical use of biomarkers.
Who should attend?
• Radiation oncologists, particularly those in the early stage of their career, who are keen
to understand how biomarkers are important for PRO
• Radiation biologists seeking information on how to maximise the clinical impact of their
scientific discoveries
• Radiation physicists and RTTs looking for an overview and update of recent and ongoing
developments in the field of biomarkers.
Programme
08:45-09:00
Introduction and overview
J. Alsner (DK)
09:00-09:30
Prognostic and predictive biomarkers
J. Alsner (DK)